Dr. Bill Sheel is a Professor and Distinguished University Scholar at the School of Kinesiology, University of British Columbia. His research focuses on the integrative physiology of exercise, particularly respiratory and cardiovascular interactions. Email: bill.sheel@ubc.ca Office: Chan Gunn Pavilion, Room 221B, Vancouver, BC Lab: Health and Integrative Physiology Laboratory Research Interests: Dr. Sheel investigates respiratory physiology during exercise, cardiovascular modulation by breathing patterns, and human performance optimization. His work spans elite athletes, aging populations, and clinical applications. Publication Trends: Recent studies include pulmonary mechanics in exercise physiology, respiratory muscle training applications, and socio-cultural factors in sports science. Collaborative works address aging interventions and environmental influences on athletic performance. Scientific Recognition: Distinguished University Scholar, UBC Laboratory & Collaborations: Leads the Health and Integrative Physiology Laboratory at UBC, focusing on respiratory-cardiovascular integration and exercise tolerance mechanisms.
Rajendra Acharya is a Professor (Artificial Intelligence in Health) at the University of Southern Queensland's School of Mathematics, Physics and Computing. He holds qualifications including BEng, MTech, two PhDs, and a DSc. His research focuses on AI applications in healthcare, pattern recognition, and medical diagnostics, with notable contributions to EEG analysis, deep learning, and disease detection. Awards include multiple Research.com Leader Awards in Computer Science for Australia and Singapore (2022–2025). His work spans over 650 publications, with high-impact studies on automated disease diagnosis via AI, including COVID-19 detection using X-rays and EEG-based seizure detection. His research interests integrate machine learning, signal processing, and healthcare technologies. He collaborates internationally and advises on AI-driven health solutions. No student list provided; however, his extensive supervision is implied through his research output.
Omer T Inan is the Regents Entrepreneur Endowed Chair and Assistant Professor at the School of Electrical and Computer Engineering (ECE) at Georgia Institute of Technology. His work bridges biomedical engineering and wearable technology, focusing on non-invasive physiological monitoring for chronic disease management. He holds a Ph.D. in Electrical Engineering from Stanford University (2009) and previously worked at Countryman Associates (2007-2013) as Chief Engineer, developing professional audio systems. Education: B.S., M.S., Ph.D. in Electrical Engineering, Stanford University (2004-2009) His research interests include medical devices for home-based cardiovascular monitoring, musculoskeletal sound analysis, and neuromodulation of stress responses. He has pioneered technologies for heart failure patients, PTSD treatment, and osteoarthritis diagnostics. Recent publications highlight innovations in AI-driven cardiac parameter estimation, motion artifact removal in seismocardiograms, and multimodal stress tracking via wearables. His work spans biomedical signal processing, clinical translation, and portable diagnostic systems. Scientific Awards 2024 IEEE Fellow 2023 IEEE Distinguished Lecturer 2023 American College of Cardiology Fellow 2022 American Institute for Medical and Biological Engineering Fellow 2021 Academy Award for Technical Achievement (The Oscars) 2018 ONR Young Investigator Award 2018 NSF CAREER Award At Georgia Tech, Inan leads the Inan Research Lab, which develops technologies for physiological monitoring and modulation. Projects include musculoskeletal sound analysis for joint health, non-invasive cardiovascular sensing, and neuromodulation to treat PTSD via vagal nerve stimulation.
Professor Peter Watkinson serves as Professor of Intensive Care Medicine at the University of Oxford and is an NHS consultant in intensive care at the Oxford University Hospitals NHS Foundation Trust. He leads the Critical Care Research Group based at the Kadoorie Centre for Critical Care Research & Education at the John Radcliffe Hospital, Oxford. His work bridges clinical practice with academic research in the field of critical care medicine through the Nuffield Department of Clinical Neurosciences. Professor Watkinson's research primarily focuses on the identification of deteriorating patients in hospital settings. His work encompasses: Design and implementation of studies on wearable monitoring devices Exploration of non-contact monitoring technologies Analysis of standard electronically-recorded patient descriptors Pattern recognition in vital signs data to predict clinical deterioration Development of electronic monitoring systems Application of human factors techniques for technology integration in healthcare Assessment of long-term effects of critical illnesses on patient quality of life The Critical Care Research Group maintains a strong collaborative link with the University of Oxford Institute of Biomedical Engineering. Using data collected from thousands of patients' vital signs both in Oxford and elsewhere, the multi-disciplinary team investigates patterns that precede and predict clinical deterioration in hospitalized patients. Recent publications indicate a strong focus on early warning scores, patient monitoring technologies, and the application of machine learning approaches to critical care data. Professor Watkinson's research output demonstrates consistent productivity with numerous 2024-2025 publications spanning systematic reviews of early warning systems, development of novel monitoring technologies, and analytical approaches to predicting patient deterioration. His work frequently employs rigorous methodology including systematic reviews, meta-analyses, and innovative study designs to address critical questions in intensive care medicine. As leader of the Critical Care Research Group, Professor Watkinson oversees a multi-disciplinary team investigating vital sign patterns and developing predictive algorithms that have direct clinical applications. The group's research has significant implications for improving patient safety through earlier recognition of clinical deterioration and more effective resource allocation in hospital settings.
Jouni Hirvonen is a Professor in the Division of Pharmaceutical Chemistry and Technology at the University of Helsinki's Faculty of Pharmacy. He serves as Supervisor for doctoral programmes in both the Doctoral Programme in Drug Research and the Doctoral Programme in Materials Research and Nanosciences. With an extensive publication record spanning over three decades, Hirvonen has contributed 384 research outputs and participated in 3 major research projects. His research interests focus on pharmaceutical technology, particularly in drug delivery systems, nanoparticles, and drug dissolution and absorption. His work bridges pharmaceutical chemistry with cutting-edge nanotechnology applications, developing innovative delivery systems for therapeutic agents. His research spans from fundamental pharmaceutical sciences to translational applications in regenerative medicine, immunotherapy, and cardiovascular pharmacology. The analysis of his recent publications reveals a strong focus on advanced drug delivery platforms, particularly utilizing nanoparticles, lipid-based systems, and biomaterials for targeted delivery. His work increasingly integrates microfluidic technology for precise nanoparticle preparation, with applications spanning cancer immunotherapy, cardiovascular repair, tendon regeneration, and inflammatory disease treatment. The trend shows a growing emphasis on combination therapies, RNA delivery, and cell-mediated drug delivery approaches. Hirvonen has received several prestigious awards throughout his career: CRS/Eurand Grand Prize Award on Innovations in Oral Drug Delivery Technologies (2007) Suomen Valkoisen Ruusun Ritarikunnan I luokan ritarimerkki (2013) The Young Scientist in the University of Kuopio (1993) University of Helsinki Quality Teaching Unit, Faculty of Pharmacy (2005) Visiting Professor award (2015) With 25 instances of supervising doctoral theses and numerous academic activities including conference organization, committee memberships, and editorial work, Hirvonen has made significant contributions to academic mentorship and institutional development. His research has been supported by projects including Generation Green, 3i REGENERATION, and IVIVRe. His work appears to involve collaboration with multiple research teams focusing on drug delivery applications across various therapeutic areas.
Kyle W. Klarich is Professor of Medicine and consultant in both the Division of Structural Heart Disease and Division of Echocardiography at Mayo Clinic. His clinical practice and research focus on structural heart disease, cardiac tumors, hypertrophic cardiomyopathies, and valvular heart disease. Dr. Klarich investigates complications prevention and quality-of-life improvement for patients with rare cardiac conditions. As Cardiovascular Disease Fellowship program director since 2010, he is extensively involved in medical education and has received multiple teaching awards including the ACGME's Parker J. Palmer Courage to Teach Award finalist recognition.
Jan Helgerud is a Professor in the Department of Circulation and Medical Imaging at the Norwegian University of Science and Technology (NTNU), Faculty of Medicine and Health Sciences. His research focuses on exercise physiology, endurance training, and cardiovascular health, with particular emphasis on aerobic capacity, muscle strength, and their clinical applications in chronic diseases and rehabilitation. Research Interests: Exercise physiology and its impact on health and disease High-intensity interval training (HIIT) adaptations in athletes and clinical populations Cardiovascular and metabolic responses to exercise Strength training in patients with rheumatic diseases, Parkinson's disease, and spinal cord injuries Physiological determinants of endurance performance in sports like cycling and cross-country skiing Recent Article Trends: Recent work emphasizes the efficacy of high-intensity training protocols for improving aerobic capacity (VO2max) and functional outcomes in diverse populations, including elite athletes and patients with long-term conditions like long-COVID or rheumatic diseases. Studies also explore mechanisms of muscle adaptation, heat tolerance in occupational settings, and digital health tools for exercise assessment. Advising & Grants: Collaborations with colleagues on randomized controlled trials for strength and endurance interventions Focus on translational research linking physiological insights to clinical outcomes Labs/Teams: Active in NTNU's Department of Circulation and Medical Imaging, contributing to interdisciplinary projects in sports science and rehabilitation medicine.
Dr. Michael Stevens is a Senior Lecturer at University of New South Wales (UNSW) Canberra , where he focuses on advanced manufacturing and biomedical device control systems . His work bridges digital manufacturing for SMEs with smart artificial heart technologies , emphasizing industry collaboration and translational research. Specializes in physiological control systems for rotary blood pumps Develops unobtrusive fall detection systems for dementia patients Leads international projects on total artificial heart development Education : B.Eng (Medical - First Class Honours), Queensland University of Technology (2010) PhD in Physiological Control for Biventricular Assist Devices, University of Queensland (2014) Research Trends show consistent focus on: Machine learning for biomedical diagnostics (2018–2025) mmWave radar and thermal sensors in patient monitoring (2021–2024) Computational fluid dynamics in artificial heart modeling (2016–2024) Physiological control algorithms for rotary blood pumps (2011–2025) Scientific Awards : UNSW Scientia Education Award (2021) for contextual teaching Heart Foundation Runner-up for "Smart Artificial Hearts" pitch (2021) ARC PGC Supervisor Award (2017) for mentoring Grants & Supervision : Holds over $6 million in competitive funding including MRFF and ARC grants. Currently supervises 4 PhD students while maintaining industry partnerships with VitalCare and BiVACOR. Labs & Facilities : Works across UNSW Engineering labs and Graduate School of Biomedical Engineering platforms, including mock circulation loops and high-performance computing clusters for CFD simulations.
Robert T. Tranquillo serves as a Distinguished McKnight University Professor in the Department of Biomedical Engineering at the University of Minnesota's College of Science and Engineering. His research focuses on developing biologically-engineered vascular grafts, heart valves, and vein valves using tissue engineering approaches. Notably, his lab has demonstrated that their engineered material, produced by skin cells (fibroblasts), has the capacity to grow, which may transform the treatment of pediatric congenital heart defects. Tranquillo's research interests center on cardiovascular tissue engineering, particularly the development of "off-the-shelf" vascular grafts and heart valves. His lab fabricates tissue-equivalents by entrapping fibroblasts in fibrin gel and constraining cell-mediated gel compaction to create aligned fibrin structures. Using bioreactors, they stimulate cells to replace aligned fibrin with collagenous matrix, creating tubes suitable for surgical implantation. Upon decellularization, these become non-immunogenic replacements that support host recellularization and growth. His current work focuses on transcatheter heart valves and vein valves, combining engineered matrix tubes with stent technology, and conferring hemocompatibility using stem cell and small molecule strategies. A key aspect of his research investigates contact guidance—the ability of cells to sense and align with fibers—which is crucial for creating tissues with prescribed alignment. His publication record shows consistent output in top journals including Nature Communications, Science Translational Medicine, and PNAS, with recent work focusing on contact guidance mechanisms, pediatric valve conduits, and transcatheter valve development. His research demonstrates a clear trajectory from fundamental biomechanics to translational applications in cardiovascular medicine. Distinguished McKnight University Professor (prestigious University of Minnesota honor) Tranquillo has mentored over 40 PhD students and postdocs who have gone on to prominent positions in academia (professors at UCLA, Rutgers, Penn State), industry (Medtronic, Abbott, Boston Scientific), and government (NSF, NRO). His lab has received substantial research funding supporting their work on tissue-engineered cardiovascular replacements. The Tranquillo Research Group maintains an active website detailing their current projects and methodologies. The Tranquillo Research Group operates within the Department of Biomedical Engineering at the University of Minnesota, with laboratory facilities focused on tissue engineering, biomechanics, and cardiovascular device development. Their work bridges fundamental cell-matrix interactions with translational applications for cardiovascular disease treatment.
Jason Au is an Assistant Professor at the University of Waterloo, specializing in vascular physiology and exercise-related cardiovascular dynamics. His research focuses on understanding complex blood flow patterns, arterial stiffness, and the impact of exercise on vascular health. He leads the Vascular Observations through Research on Technology and Exercise (VORTEX) Lab, integrating advanced imaging techniques like high-frame-rate ultrasound. Dr. Au holds a BSc and PhD in Kinesiology from McMaster University and a Postdoctoral Fellowship in Electrical & Computer Engineering at the University of Waterloo. His research interests include three main areas: 1) Complex blood flow and wall motion in arteries/veins, 2) Sedentary behavior/exercise exposure on vascular risk, and 3) Novel biomarkers of vascular disease progression. His work combines experimental models with computational approaches to study vascular health comprehensively. Key publications highlight innovations in ultrasound imaging (e.g., vector projectile imaging) and physiological mechanisms like arterial wall motion regulation. Dr. Au’s lab offers graduate supervision across MSc, PhD, and postdoctoral levels, with active projects exploring exercise countermeasures to vascular disease and technological advancements in medical imaging. Laboratory activities emphasize translational research, bridging basic science and clinical applications to improve cardiovascular health outcomes. Collaborations span engineering, physiology, and clinical domains to address unresolved questions in vascular biology.
Michele Boon is a Lecturer in Nursing at Glasgow Caledonian University's School of Health and Life Sciences. She maintains an active research profile with 29 research outputs spanning from 2004 to 2025, demonstrating increasing productivity in recent years with 6 publications in 2021 alone. She is currently accepting PhD students and has established herself as a methodological expert in public health research. Dr. Boon's research interests center on public health, epidemiology, health services research, and health policy. Her work emphasizes systematic review methodology, particularly through her role as Methods Editor for Cochrane Public Health. Key research areas include palliative care for respiratory conditions, social network interventions for cardiac rehabilitation, health inequalities, and women's health. Her research contributes significantly to multiple UN Sustainable Development Goals. Her publication record shows consistent output with increasing impact, particularly in the last five years. Notable works include the European Respiratory Society clinical practice guideline on palliative care (2023) with 68 citations, and the Cochrane review on social network interventions for cardiac rehabilitation (2023). Her research demonstrates strong interdisciplinary connections across public health, clinical medicine, and social policy. Dr. Boon has received significant recognition through external appointments: Senior Member, ERS Clinical Practice Guidelines Methodology Network, European Respiratory Society (Apr 2022-Apr 2025) Associate Editor, Health policies, systems and management in high-income countries, BMC Public Health (Aug 2020-present) Methods Editor, Cochrane Public Health (Sept 2019-present) She currently leads or contributes to two major research projects: the NRSI-ROB Cochrane Public Health Project as Principal Investigator, and the COVID-19 and the Centrality of Care project as Co-Investigator. Her work has been picked up by numerous news outlets, referenced in policy documents, and has significant social media engagement, demonstrating real-world impact beyond academia.
Job J.A.M. van der Palen is a Full Professor in Cognition, Data and Education at University of Twente, with a long-standing external position as Clinical Epidemiologist at Medisch Spectrum Twente (MST) since June 1, 1993. His academic career spans over three decades with substantial research output including 528 publications, 16,222 citations, and an h-index of 60. He maintains an active research profile with 13 publications already in 2025, demonstrating continued scholarly engagement. Dr. van der Palen's research interests focus on chronic respiratory diseases, particularly Chronic Obstructive Pulmonary Disease (COPD) and asthma management. His work extends to eHealth interventions, randomized controlled trials methodology, and more recently, breast cancer research and delirium detection in elderly cardiac patients. His fingerprint analysis reveals strong expertise in Patient Medicine and Dentistry (100%), Inpatient Medicine (53%), COPD (50%), and Obstructive Lung Disease (37%). His recent publications (2024-2025) demonstrate a clear trend toward interdisciplinary research combining medical domains with data science approaches. There's a notable focus on personalized medicine through intensive longitudinal data analysis, AI-supported systematic reviews, and eHealth interventions for chronic disease management. His work bridges clinical practice with data-driven approaches, particularly evident in studies on COPD exacerbation action plans, pediatric asthma management, and advanced detection methods for postoperative complications. Best oral presentation MST Wetenschapsdag 2023 (as contributor) Dr. van der Palen has supervised 20 students' work according to institutional records, with recent activities including program committee membership for the Medisch Spectrum Twente Wetenschapsdag 2023. His research network spans multiple institutions, with significant collaborations in the Netherlands and internationally, particularly in respiratory medicine and clinical epidemiology. He has contributed to numerous randomized controlled trials and cohort studies focusing on chronic disease management and patient outcomes. His current research activities involve multiple teams working on COPD management (RE-SAMPLE cohort study), pediatric asthma (CIRCUS study), and breast cancer research. The Brain Pro-TCT study demonstrates his involvement in innovative approaches to postoperative care for elderly patients. His work with AI-supported screening methods indicates engagement with cutting-edge data analysis techniques in medical research.
Kari Alitalo is an Academy Professor and Research Director at HUS Radiology and Pathology, University of Helsinki. He serves as a Supervisor in the Doctoral Programme in Integrative Life Science and the Doctoral Programme in Biomedicine. Alitalo directs the CAN-PRO - Translational Cancer Medicine Program and has led the Cancer Biology Research Programme at the University of Helsinki since 1999. His research primarily focuses on blood and lymphatic vessel growth factors with applications in cancer treatment and cardiovascular diseases. Alitalo's work spans angiogenesis, lymphangiogenesis, molecular biology, and translational medicine. His research group has made significant contributions to understanding vascular endothelial growth factors and their therapeutic applications. Alitalo's publication record shows consistent productivity with approximately 670 research outputs. His recent work (2023-2025) demonstrates continued focus on lymphatic system biology, vascular growth factors, and their therapeutic applications in cancer and cardiovascular diseases. The publications reveal a strong emphasis on molecular mechanisms of lymphangiogenesis, tumor angiogenesis, and potential therapeutic interventions. A.I. Virtanen Prize (2013) Biomedicum Helsinki lecture and Medal (2010) Eric K Fernström Foundation's Nordic Prize (2005) Finnish Science Prize (2013) Louis-Jeantet Prize For Medicine (2006) Professor Alitalo has supervised numerous doctoral students, with 52 dissertation supervisor or co-supervisor activities documented. He currently leads multiple active research projects including Cancer Foundation 2025/Alitalo, Biocenter Finland FIRI2023, and Juselius 2023-2026. His research group continues to explore vascular biology with significant implications for cancer treatment and cardiovascular medicine.
Ify Mordi, PhD, serves as a Clinical Senior Lecturer and Honorary Consultant in Teaching and Research within the Division of Cardiovascular Research at the University of Dundee's School of Medicine. With an impressive research portfolio spanning over a decade, Dr. Mordi has published 139 research outputs and secured significant funding from organizations including the British Heart Foundation and Juvenile Diabetes Research Foundation. Her work contributes to UN Sustainable Development Goals related to good health and well-being through innovative cardiovascular research. Dr. Mordi's research focuses on the intersection of cardiovascular disease and diabetes, with particular expertise in heart failure (especially heart failure with preserved ejection fraction), aortic stenosis, and coronary artery disease. Her work increasingly incorporates artificial intelligence applications in cardiovascular medicine, including groundbreaking research using retinal imaging to predict cardiovascular outcomes. She leads multiple major research initiatives including the SOPHIST trial investigating Sotagliflozin in patients with heart failure symptoms and type 1 diabetes, and the UK HFpEF Registry in collaboration with the University of Manchester. Analysis of Dr. Mordi's recent publications reveals a strong trend toward integrating advanced analytics and AI with traditional cardiovascular research. Her work spans genetic epidemiology, clinical trials, population health studies, and innovative diagnostic approaches. The research demonstrates growing emphasis on precision medicine approaches for cardiovascular disease, particularly in diabetic populations, and the development of non-invasive diagnostic tools that could transform clinical practice. Dr. Mordi actively contributes to academic mentoring through PhD examinations and serves as an invited speaker at international conferences. Her research has received significant media attention, with coverage in 13 news outlets and mentions across social media platforms, highlighting the translational impact of her work. She has been involved in multiple high-impact collaborative projects including the iDiabetes Platform for enhanced phenotyping of diabetes patients and the REACH-HFpEF study examining home-based rehabilitation for heart failure patients. Through her leadership in the British Heart Foundation-funded Clinical Fellowship focused on improving prediction and prevention of heart failure in type 1 diabetes, Dr. Mordi is establishing herself as a key investigator in the field of cardio-diabetology. Her research program bridges basic science, clinical application, and health services research to address critical gaps in cardiovascular care for diabetic patients.
Prof. SG (Guid) Oei is a full-time faculty member at the Eindhoven University of Technology (TU/e) in the Biomedical Diagnostics Lab under the Department of Electrical Engineering. He serves as a leading academic in the Eindhoven MedTech Innovation Center and the Center for Care & Cure Technology Eindhoven , focusing on advanced signal processing systems for maternal-fetal health diagnostics. Primary Affiliation: Professor , Electrical Engineering, TU/e Research Centers: Eindhoven MedTech Innovation Center, Biomedical Diagnostics Lab, Center for Care & Cure Technology Eindhoven Research Focus : Developing non-invasive fetal monitoring technologies, including electrohysterography and speckle tracking echocardiography , to improve detection of fetal distress, preterm birth prediction, and maternal-fetal health outcomes. His work bridges biomedical diagnostics with machine learning, emphasizing real-time clinical applications. Scientific Contributions : Over 288 research outputs with 4568 citations, including pioneering studies on: Fetal myocardial deformation analysis AI-enhanced cardiotocogram interpretation Extra-uterine life support system design Impact of maternal mental health on labor outcomes Optimization of uterine monitoring techniques Collaborative Networks : Works with key researchers like Jan WM Bergmans (NeuroPlatform), Massimo Mischi (Biomedical Diagnostics), and Judith OEH van Laar on projects spanning prenatal diagnostics, maternal-fetal coupling, and simulation-based obstetric training.
